Division of Cardiovascular Medicine, Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine, El Paso, TX.
Division of Cardiovascular Medicine, Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine, El Paso, TX.
Curr Probl Cardiol. 2021 Jun;46(6):100822. doi: 10.1016/j.cpcardiol.2021.100822. Epub 2021 Feb 27.
Ultrasound utilization during access enables precise vessel cannulation. We sought to evaluate the outcomes of ultrasound guided dorsal distal radial artery (DDRA), radial, and ulnar cardiac catheterization (CC) and percutaneous coronary intervention (PCI). We performed a prospective observational study of 224 patients (58 ± 12 years) at an academic medical center from October 2016 to March 2020 (median follow-up of 13 months) and compared the outcomes of ultrasound guided DDRA, ulnar, or radial artery CC and PCI. Groups were divided into DDRA (n = 18, 8.0%), ulnar (n = 94, 42.0%) and radial access (n = 112, 50.0%). Primary endpoints included the number of access attempts and conversion to femoral access. Secondary endpoints included all-cause mortality, cardiac mortality, acute myocardial infarction (AMI), stroke, repeat revascularization, stent thrombosis, in-stent restenosis, and access site complications. In the primary endpoints, no significant difference was found amongst groups in the number of access attempts (P = 0.272) or conversion to femoral access (P = 0.381). In the radial group (59 ± 11 years, median follow-up of 16 months), 2 cardiac mortalities (1 lymphocytic myocarditis, 1 AMI) and 2 noncardiac mortalities occurred. None of the secondary endpoints occurred in the DDRA (66 ± 17 years, median follow-up of 13 months) or ulnar group (56 ± 11 years, median follow-up of 14 months). DDRA and ulnar PCI was safe and efficacious with no complications. Femoral conversion or the number of access attempts was not different between DDRA, ulnar, or radial. Therefore, DDRA and ulnar are viable alternatives for PCI, which can preserve radial for future use.
超声引导下的入路可以实现精确的血管插管。我们旨在评估超声引导下背侧尺动脉(DDRA)、桡动脉和尺动脉心导管术(CC)和经皮冠状动脉介入治疗(PCI)的结果。我们在 2016 年 10 月至 2020 年 3 月对一家学术医疗中心的 224 例患者(58±12 岁)进行了前瞻性观察研究(中位随访 13 个月),并比较了超声引导下的 DDRA、尺动脉或桡动脉 CC 和 PCI 的结果。各组分为 DDRA(n=18,8.0%)、尺动脉(n=94,42.0%)和桡动脉入路(n=112,50.0%)。主要终点包括入路尝试次数和转换为股动脉入路的次数。次要终点包括全因死亡率、心脏死亡率、急性心肌梗死(AMI)、卒中和再次血运重建、支架血栓形成、支架内再狭窄和入路部位并发症。在主要终点方面,各组之间入路尝试次数(P=0.272)或转换为股动脉入路的次数(P=0.381)无显著差异。在桡动脉组(59±11 岁,中位随访 16 个月),2 例发生心脏死亡(1 例淋巴细胞性心肌炎,1 例 AMI)和 2 例非心脏死亡。DDRA 组(66±17 岁,中位随访 13 个月)和尺动脉组(56±11 岁,中位随访 14 个月)均未发生次要终点。DDRA 和尺动脉 PCI 安全有效,无并发症。DDRA、尺动脉和桡动脉之间的股动脉转换或入路尝试次数无差异。因此,DDRA 和尺动脉是 PCI 的可行替代方案,可以保留桡动脉以备将来使用。